Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters

NCT05365451 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Interaction
Endogenous Biomarkers

Interventions

DRUG: MetFORMIN Oral Solution
DRUG: Cimetidine 400 MG
DRUG: Furosemide Oral Liquid Product
DRUG: Probenecid 500 MG

Sponsor

Washington State University

Collaborators

[object Object]
[object Object]